Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH4 | Q9H3N8 | 2/20 | 0.34 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1176767 | 0.87 | ALDH1A1 (0.30) | SCN9A | |
| Trifluoroacetic Acid SCHEMBL1583669 | 0.87 | HRH4 (0.36) | HRH4SCN9APKMHRH3 | |
| Trifluoroacetic Acid SCHEMBL28429222 | 0.84 | PIM1 (0.38) | HRH4 | |
| Trifluoroacetic Acid SCHEMBL1583592 | 0.84 | MEN1 (0.39) | HRH4SCN9APKMHRH3 | |
| Trifluoroacetic Acid SCHEMBL71716 | 0.83 | HRH4 (0.37) | HRH4SCN9APKMHRH3 | |
| Trifluoroacetic Acid SCHEMBL1206539 | 0.83 | HRH4 (0.37) | HRH4SCN9APKMHRH3 | |
| Trifluoroacetic Acid SCHEMBL2352665 | 0.83 | P2RX7 (0.39) | HRH4SCN9APKMHRH3 | |
| Trifluoroacetic Acid SCHEMBL28710666 | 0.81 | PKM (0.37) | HRH4SCN9APKMHRH3 | |
| Trifluoroacetic Acid SCHEMBL28691408 | 0.81 | PKM (0.34) | HRH4SCN9APKMHRH3 | |
| Trifluoroacetic Acid SCHEMBL31571014 | 0.81 | TSHR (0.45) | HRH4PKMHRH3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7892574-B2 | In situ applying oxazolidinone to ear, skins | PHARMACIA & UPJOHN COMPANY, LLC (US) | 2011-02-22 | — | — | US | disclosed |
| EP-1096934-B1 | OXAZOLIDINONES TO TREAT EYE INFECTIONS | PHARMACIA & UPJOHN CO LLC (US) | 2005-09-21 | — | — | EP | disclosed |
| EP-1304107-B1 | Use of oxazolidinines derivatives for treating psoriasis | PHARMACIA & UPJOHN CO LLC (US) | 2005-07-06 | — | — | EP | disclosed |
| CN-1168447-C | Use of oxazolidinones for the production of a medicament for the treatment of non-topical infections | �������Ŷ���Լ��������˾ | 2004-09-29 | — | — | CN | disclosed |
| US-6740652-B2 | Oxazolidinones to treat eye infections | PHARMACIA & UPJOHN COMPANY | 2004-05-25 | — | — | US | disclosed |
| US-20040072841-A1 | Topical administration of oxazolidinones for transdermal delivery | FORD CHARLES W (US) | 2004-04-15 | — | — | US | disclosed |
| US-6613349-B2 | Administration of oxazolidinones for transdermal delivery | PHARMACIA & UPJOHN COMPANY | 2003-09-02 | — | — | US | disclosed |
| EP-1304107-A2 | Use of oxazolidinines derivatives for treating psoriasis | PHARMACIA & UPJOHN COMPANY (US) | 2003-04-23 | — | — | EP | disclosed |
| EP-0882041-B1 | PIPERAZINONEPHENYLOXAZOLIDINONE DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS | ASTRAZENECA AB (SE) | 2003-03-26 | — | — | EP | disclosed |
| EP-1032386-B1 | USE OF OXAZOLIDINONE DERIVATIVES FOR TREATING ARTHRITIS | UPJOHN CO (US) | 2003-02-26 | — | — | EP | disclosed |
| EP-1096934-A1 | OXAZOLIDINONES TO TREAT EYE INFECTIONS | PHARMACIA & UPJOHN COMPANY (US) | 2001-05-09 | — | — | EP | disclosed |
| EP-1083900-A2 | TOPICAL ADMINISTRATION OF OXAZOLIDINONES FOR TRANSDERMAL DELIVERY | PHARMACIA & UPJOHN COMPANY (US) | 2001-03-21 | — | — | EP | disclosed |
| EP-1032386-A1 | USE OF OXAZOLIDINONE DERIVATITIVES FOR TREATING PSORIASIS, ARTHRITIS AND REDUCING THE TOXICITY OF CANCER CHEMOTHERAPY | PHARMACIA & UPJOHN COMPANY (US) | 2000-09-06 | — | — | EP | disclosed |
| US-6069145-A | AGAINST ANTIBIOTIC RESISTANT BACTERIA | ZENECA LIMITED (GB) | 2000-05-30 | — | — | US | disclosed |
| US-6040306-A | Method of treating psoriasis, arthritis and reducing the toxicity of cancer chemotherapy | PHARMACIA & UPJOHN COMPANY | 2000-03-21 | — | — | US | disclosed |
| WO-2000003710-A1 | OXAZOLIDINONES TO TREAT EYE INFECTIONS | PHARMACIA & UPJOHN COMPANY (US) | 2000-01-27 | — | — | WO | disclosed |
| WO-1999062504-A2 | TOPICAL ADMINISTRATION OF OXAZOLIDINONES FOR TRANSDERMAL DELIVERY | PHARMACIA & UPJOHN COMPANY (US) | 1999-12-09 | — | — | WO | disclosed |
| WO-1999025344-A1 | USE OF OXAZOLIDINONE DERIVATIVES FOR TREATING PSORIASIS, ARTHRITIS AND REDUCING THE TOXICITY OF CANCER CHEMOTHERAPY | PHARMACIA & UPJOHN COMPANY (US) | 1999-05-27 | — | — | WO | disclosed |
| EP-0882041-A1 | PIPERAZINONEPHENYLOXAZOLIDINONE DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS | AstraZeneca AB (SE) | 1998-12-09 | — | — | EP | disclosed |
| WO-1997027188-A1 | PIPERAZINONEPHENYLOXAZOLIDINONE DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS | ZENECA LIMITED (GB) | 1997-07-31 | — | — | WO | disclosed |